Who owns TALARIS THERAPEUTICS INC?
- CUSIP Number: 87410c104
Tip: Access positions for across all investors
Analyze quarterly positions in Talaris Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Talaris Therapeutics stock
Who bought or sold TALARIS THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Affinity Asset Advisors | 400k | $1.1M | 100% | Sep 2023 |
|
Bridgeway Capital Management | 301k | $846k | 102% | Sep 2023 |
|
Geode Capital Management | 206k | $579k | -1% | Sep 2023 |
|
Renaissance Technologies | 197k | $552k | -55% | Sep 2023 |
|
BlackRock | 127k | $356k | -3% | Sep 2023 |
|
State Street Corporation | 65k | $184k | 0% | Sep 2023 |
|
Morgan Stanley | 36k | $102k | -25% | Sep 2023 |
|
Northern Trust | 31k | $86k | 22% | Sep 2023 |
|
XTX Topco | 22k | $61k | 9% | Sep 2023 |
|
Susquehanna International | 18k | $52k | -43% | Sep 2023 |
|
Freedom Wealth Alliance | 16k | $45k | 100% | Sep 2023 |
|
Qube Research & Technologies | 10k | $28k | -71% | Sep 2023 |
|
FMR | 5.6k | $16k | 0% | Sep 2023 |
|
Tower Research Capital | 962.00 | $2.7k | 100% | Sep 2023 |
|
Who sold out of Talaris Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Blackstone Group | Sep 2023 | 8.1M | $23M |
Nantahala Capital Management | Sep 2023 | 3.0M | $8.3M |
Qiming U.S. Ventures Management | Sep 2023 | 2.9M | $8.2M |
RA Capital Management | Sep 2023 | 2.4M | $6.8M |
BML Capital Management | Sep 2023 | 2.0M | $5.6M |
Balyasny Asset Management | Sep 2023 | 1.5M | $4.1M |
Vanguard Group | Sep 2023 | 1.1M | $3.1M |
Dr. Jeffrey R. Jay, M.D. | Sep 2023 | 1.0M | $2.8M |
Artal Group | Sep 2023 | 914k | $2.6M |
QVT Financial | Sep 2023 | 589k | $1.7M |
venBio Select Advisor | Sep 2023 | 500k | $1.4M |
Jpmorgan Chase & Co | Sep 2023 | 388k | $1.1M |
Dimensional Fund Advisors | Sep 2023 | 273k | $767k |
Walleye Trading Advisors | Sep 2023 | 263k | $738k |
Two Sigma Investments | Sep 2023 | 246k | $691k |
Two Sigma Advisers | Sep 2023 | 227k | $637k |
Acuitas Investments | Sep 2023 | 195k | $547k |
Millennium Management | Sep 2023 | 158k | $443k |
Citadel Advisors | Sep 2023 | 115k | $322k |
Corsair Capital Management | Jun 2023 | 55k | $167k |
Man Group | Sep 2023 | 50k | $142k |
Marquette Asset Management | Sep 2023 | 40k | $113k |
Y-Intercept | Jun 2023 | 32k | $98k |
Bank of New York Mellon | Sep 2023 | 21k | $58k |
Barclays | Sep 2023 | 18k | $50k |
Springbok Capital Management | Jun 2023 | 16k | $48k |
Bailard | Sep 2023 | 15k | $42k |
Charles Schwab Investment Management | Sep 2023 | 14k | $39k |
Bank Of Montreal | Sep 2023 | 13k | $35k |
Acadian Asset Management | Jun 2023 | 11k | $34k |
Bank of America Corporation | Sep 2023 | 11k | $30k |
Goldman Sachs Group | Sep 2023 | 8.7k | $246k |
Federated Investors | Sep 2023 | 2.4k | $6.6k |
Pnc Financial Services | Sep 2023 | 1.9k | $5.4k |
Rhumbline Advisers | Sep 2023 | 1.2k | $3.3k |